Nedumannil R, Ritchie D, Bajel A, Ng AP, et al. Real-world utility of early measurable residual disease assessments by multi-parametric flow cytometry in adult patients with B-lymphoblastic leukemia receiving Hyper-CVAD induction chemotherapy. Eur J Haematol 2022 Nov 2. doi: 10.1111/ejh.13890.
PMID: 36321745